Lab scientists and data scientists often speak different languages and that miscommunication can slow down important research. In this interview, Ian Kerman shares how his team is working to break ...

Understand the challenges and impacts of the 3Rs on animal welfare in research with Dr. Liz Nunamaker's expert interview.

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...

Stanford scientists have successfully grown heart and liver organoids that include functioning blood vessels. This ...

Discover how SB000 offers a safe alternative for cell rejuvenation without activating dangerous pluripotency pathways.

Learn about the innovative method to create aptamers that could revolutionise treatments for infectious diseases.

Explore the potential of protein design with the new deep learning approach from Chongqing University to enhance binding ...

While ADCs continue to attract attention in oncology, many developers remain focused on antibodies – overlooking the critical role of payload design. At Sygnature Discovery, Dr Joshua Greally is ...

Explore GPCR-targeting therapies and their untapped potential in drug development, making up 30-35 percent of approved drugs.

Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...

Alltrna is redefining the future of rare disease treatment with engineered tRNA therapeutics that target genetic mutations - not just individual diseases. CEO Michelle Werner shares how this bold, ...